- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for Vasomedical Inc (VASO)
| Open: | 0.1710 | Day's Range: | 0.1710 - 0.1809 | Volume: | 27,094 |
|---|---|---|---|---|---|
| Previous Close: | 0.1815 | 52wk Range: | 0.1010 - 0.2649 | 1-Yr Rtn: | -26.94% |
Key Statistics for VASO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0200 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 29.22 |
| Shares Outstanding (M) | 163.26 |
| 30 Day Average Volume | 64,832 |
| Price/Book (mrq) | 3.4879 |
| Price/Sale (ttm) | 0.8348 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for VASO
Company Profile & Key Executives for VASO
Vasomedical, Inc. commercializes the EECP enhanced external counterpulsation system. The Company's product is a microprocessor-based medical device for the noninvasive, atraumatic treatment of patients with coronary artery disease. Vasomedical's EECP is marketed worldwide to hospitals, clinics, and other cardiac health care providers.
| Jun MaPresident/CEO | Michael J BeecherChief Financial Officer |
| Jonathan P NewtonVP:Finance /Controller |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
VASO News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page